Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma

被引：0
|
作者：
Colomba, E. [1 ]
Alexandre, J. [2 ]
Le Teuff, G. [3 ]
Coupez, D. [4 ]
Genestie, C. [5 ]
Ray-Coquard, I. L. [6 ]
Brachet, P. E. [7 ]
Sajous, C. [8 ]
De Percin, S. [9 ]
Fabbro, M. [10 ]
Delanoy, N. [11 ]
Joly, F. [12 ]
Pautier, P. [13 ]
Frenel, J-S. [14 ]
Leary, A. [15 ]
机构：
[1] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] Hop Cochin Site Port Royal, AP HP, Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Biostatist, Villejuif, France
[4] CHU Nantes Hotel Dieu, Oncol, Nantes, France
[5] Inst Gustave Roussy, Pathol, Villejuif, France
[6] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[7] Ctr Francois Baclesse, Med Oncol Dept, Caen, France
[8] Inst Cancerol Hosp Civils Lyon IC HCL, Med Oncol Dept, Lyon, France
[9] Hop Univ Paris Ctr Med Oncol, Hop Cochin, Paris, France
[10] Inst Canc Montpellier, Dept Med Oncol, Montpellier, France
[11] Hop European George Pompidou, Dept Med Oncol, Paris, France
[12] Ctr Francois Baclesse, Med Oncol, Caen, France
[13] Inst Gustave Roussy, Dept Med, Villejuif, France
[14] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Med Oncol, Saint Herblain, France
[15] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
801P
引用
收藏
页码：S763 / S763
页数：1
相关论文
共 50 条
  • [31] First-line chemotherapy trial in advanced endometrial carcinoma
    Siqing Fu
    John J. Kavanagh
    Current Oncology Reports, 2004, 6 (6) : 483 - 483
  • [32] KEYNOTE-177: Phase 3, open-label, randomized study of first-line pembrolizumab (Pembro) versus investigator-choice chemotherapy for mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal carcinoma (mCRC).
    Diaz, Luis A.
    Le, Dung T.
    Yoshino, Takayuki
    Andre, Thierry
    Bendell, Johanna C.
    Rosales, Minori
    Kang, S. Peter
    Lam, Bao
    Jager, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [33] Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review
    Gim, Gahyun
    Kim, Yeseul
    Park, Yeonggyeong
    Kim, Min Jeong
    Nam, Myungwoo
    Yang, Woojung
    Duarte, Samantha E.
    Jung, Chan Mi
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    ONCOLOGIST, 2022, 27 (07): : 525 - 531
  • [34] Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.
    Sinicrope, Frank A.
    Chakrabarti, Sakti
    Eiring, Rachel
    Mitchelll, Jessica L.
    Finnes, Heidi D.
    Hubbard, Joleen Marie
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
    Amonkar, Mayur M.
    Chase, Monica
    Myer, Nicole M.
    Wang, Tongtong
    Turzhitsky, Vladimir
    Spira, Alexander
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [36] On pembrolizumab (Keytruda) in microsatellite instability-high/mismatch repair deficient (MSI-h/MMRd) metastatic colorectal cancer (mCRC)
    Bekaii-Saab, Tanios S.
    ONCOLOGY-NEW YORK, 2021, 35 (07): : 380 - 380
  • [37] Neoadjuvant Immunotherapy Effectiveness in Patients With Microsatellite Instability-High (MSI-H) Gastric Cancer
    Chubenko, Viacheslav A.
    Navmatulya, Alexander Y.
    Gerk, Ivan A.
    Sarmatov, Artem A.
    V. Egorenkov, Vitaliy
    Shelekhova, Ksenia A.
    Zykov, Evgeny N.
    V. Chernobrivceva, Vera
    Volkov, Nikita M.
    Moiseyenko, Vladimir M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [38] Genomic characterization and translational immunotherapy of microsatellite instability-high (MSI-H) in cholangiocarcinoma.
    Yang, Xu
    Lian, Baofeng
    Li, Yiran
    Xue, Jinnan
    Wang, Yunchao
    Wang, Yanyu
    Xun, Ziyu
    Zhang, Nan
    Sun, Huishan
    Long, Junyu
    Song, Zhijian
    Lu, Leilei
    Pan, Jie
    Zhao, Lin
    Guan, Mei
    Yang, Xiaobo
    Mao, Yilei
    Sang, Xinting
    Wang, Kai
    Zhao, Hai-Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers
    Pureur, Dimitri
    Rodrigues, Manuel
    Turpin, Anthony
    BULLETIN DU CANCER, 2021, 108 (03) : 229 - 231
  • [40] The efficacy of pembrolizumab in patients with high-frequency microsatellite instability (MSI-H) solid tumors
    Sugimoto, Naotoshi
    Hasegawa, Akiko
    Takada, Ryoji
    Abe, Yutaro
    Kai, Yugo
    Fukutake, Nobuyasu
    Ikezawa, Kenji
    Yamamoto, Sachiko
    Watanabe, Masahiro
    Hisa, Tsuyoshi
    Oota, Yukinobu
    Kuno, Ikumi
    Otsuka, Tomoyuki
    Nishio, Minako
    Kudo, Toshihiro
    Fujisawa, Fumie
    Yagi, Toshinari
    Ohkawa, Kazuyoshi
    Kamiura, Shoji
    Imamura, Fumio
    ANNALS OF ONCOLOGY, 2021, 32 : S302 - S302
12345